S. Lawton

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

G. Canonica, R. Dahl, G. Roberts, 2016, Allergy and asthma proceedings.

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.

M. Calderón, H. Nelson, F. Allen-Ramey, 2015, The journal of allergy and clinical immunology. In practice.

208 Compliance and Persistence to Grass Immunotherapy Treatment is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study

J. Andreasen, S. Lawton, S. B. Bæch, 2012, The World Allergy Organization Journal.

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets

K. Lund, Morten Lindholm, K. Ohashi-Doi, 2022, Current therapeutic research, clinical and experimental.

Ability to handle, and patient preference for, insulin delivery devices in visually impaired patients with type 2 diabetes

C. Fox, Charles Fox, Carol McKinnon, 2002 .

Accuracy and precision of the NovoPen 3 insulin delivery device after mechanical and temperature stresses.

Carsten M Kristensen, N. Khutoryansky, S. Lawton, 2002, Endocrine Practice.

A Review of 20 Years’ Experience with the Novopen® Family of Insulin Injection Devices

K. Jensen, Jørn Rex, Klaus H Jensen, 2006, Clinical drug investigation.

Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma

D. Bernstein, H. Nelson, H. Nolte, 2017, Postgraduate medicine.

The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.

K. Lund, K. Ohashi-Doi, H. Nakazawa, 2019, Clinical therapeutics.